$ARXS

Arxis Growth Could Depend on Pricing, Deals, Public Track Record, RBC Says

Arxis (ARXS) could benefit from steady revenue growth, stronger pricing, more acquisitions, and high margins, but its current valuation and concerns about defense budget growth may limit near-term upside, RBC Capital Markets said in a note Monday.The investment firm said Arxis' midterm revenue growth target of about 9% looks conservative, with volume, pricing, and new business expected to support sales, while the company may have room to raise prices because about 90% of its products are proprietary and only about 15% of revenue is covered by long-term agreements.Acquisitions are the biggest possible upside driver, as Arxis has completed 32 deals since 2019 and expects to keep pursuing about five deals a year, RBC said, adding that Arcline's continued role in larger deals should help Arxis, while the company's recent IPO means investors will want to see a stronger public track record.RBC started coverage of Arxis with a sector perform rating and a $39 price target, saying that the stock's current valuation already reflects much of the near-term opportunity, with better pricing or faster deal activity offering possible upside.Price: $36.97, Change: $+1.87, Percent Change: +5.33%

Arxis' Organic Growth, Compounder Potential Currently Undervalued, Morgan Stanley Says

Arxis' (ARXS) organic growth and compounder potential are undervalued at current stock price levels, Morgan Stanley said in a Monday note.The company, which provides highly engineered electronic and mechanical components designed for harsh environments in the defense and space sectors, focuses on proprietary products, from which it derives around 90% of its revenue, Morgan Stanley analysts said. This offers Arxis pricing power and a sustainable competitive moat, the analysts noted.Highly diversified across products, end markets, customers, and platforms, Arxis is poised for organic and inorganic growth, and it has a solid history of acquiring and integrating strategic targets for value creation and cross-selling opportunities, the analysts said.Arxis displays the marks of an "industrial compounder" with its durable competitive advantages and successful track record in acquisitions. The company gives investors wide exposure to positive industry trends in defense and space, commercial aerospace, and specialized industrial technology, according to the note.Morgan Stanley initiated coverage of the company's stock at overweight with a price target of $44.Price: $36.82, Change: $+1.72, Percent Change: +4.89%

Baird Initiates Arxis at Outperform With $55 Price Target

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

William Blair Initiates Arxis at Outperform

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Rothschild & Co Redburn Initiates Arxis at Buy With $40 Price Target

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Goldman Sachs Initiates Arxis at Buy With $53 Price Target

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Citigroup Initiates Arxis at Buy With $42 Price Target

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Jefferies Initiates Arxis at Buy With $42 Price Target

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Wells Fargo Initiates Arxis at Overweight With $42 Price Target

RBC Capital Initiates Coverage on Arxis With Sector Perform Rating, $39 Price Target

Morgan Stanley Initiates Arxis at Overweight With $44 Price Target

Arxis Insider Bought Shares Worth $1,500,800, According to a Recent SEC Filing

Kevin Scott Perhamus, Director, President and Chief Executive Officer, on April 16, 2026, executed a purchase for 53,600 shares in Arxis (ARXS) for $1,500,800. Following the Form 4 filing with the SEC, Perhamus has control over a total of 3,573,133 Class A common shares of the company, with 3,573,133 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2093536/000119312526164663/xslF345X05/ownership.xml

Arxis Insider Bought Shares Worth $1,008,000, According to a Recent SEC Filing

Azad Sid Badakhsh, Chief Financial Officer and Treasurer, on April 16, 2026, executed a purchase for 36,000 shares in Arxis (ARXS) for $1,008,000. Following the Form 4 filing with the SEC, Badakhsh has control over a total of 403,864 Class A common shares of the company, with 403,864 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2093536/000119312526164685/xslF345X05/ownership.xml

Arxis Shares Rise in Nasdaq Debut

Arxis (ARXS) shares were higher following their debut on Nasdaq Thursday.The shares were up more than 37% at $38.61 in afternoon trading after opening at $38.00.The manufacturer of electronic components priced its upsized initial public offering of 40.5 million class A shares at $28 apiece. It has granted its underwriters a 30-day option to purchase up to about 6.08 million additional shares.Price: $38.61, Change: $+10.61, Percent Change: +37.89%